Literature DB >> 20421785

Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population.

Hung-Yu Chang1, Chun-Wu Tung, Pei-Hsien Lee, Chen-Chou Lei, Yung-Chien Hsu, Hsun-Hao Chang, Hsueh-Fang Yang, Long-Chuan Lu, Ming-Chung Jong, Chiu-Yueh Chen, Kuei-Ying Fang, Yu-Shiu Chao, Ya-Hsueh Shih, Chun-Liang Lin.   

Abstract

INTRODUCTION: Hyperuricemia in the general population remains controversial, in terms of it being considered a risk factor for chronic kidney disease (CKD). Within this context, we evaluated the effects of hyperuricemia on renal function in older Taiwanese adults.
METHODS: From January 2002 to December 2006, we conducted a community-based medical screening program involving 31,331 subjects older than 40 years. According to the National Kidney Foundation guidelines, stage 3 to 5 patients with CKD were included for analysis. Age, body mass index, systolic blood pressure, fasting plasma glucose, triglyceride, cholesterol and proteinuria were considered potential confounders.
RESULTS: Participants with hyperuricemia tended to have higher systolic blood pressure, sugar levels, body mass index, and cholesterol and triglyceride levels but lower estimated glomerular filtration rate (eGFR) levels; eGFR negatively correlated with serum uric acid level. By using multiple logistic regression models before and after adjusting for any confounding factors, we noted that participants with hyperuricemia had a 4.036-fold (odds ratios = 4.036) and 3.649-fold (odds ratios = 3.649) increased risk for CKD, respectively, compared with the control group. We used multiple linear regression analysis to examine the association of serum uric acid level and eGFR at different stages of CKD; significance was found only in participants with stage 3 CKD and not in participants with stages 4 or 5.
CONCLUSIONS: Hyperuricemia is an independent risk factor for CKD in middle-aged and elderly Taiwanese adults. Thus, an effective screening program that identifies people with hyperuricemia is warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421785     DOI: 10.1097/MAJ.0b013e3181db6e16

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  33 in total

1.  Uric acid, hypertension, and chronic kidney disease among Alaska Eskimos: the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study.

Authors:  Stacey E Jolly; Mihriye Mete; Hong Wang; Jianhui Zhu; Sven O E Ebbesson; V Saroja Voruganti; Anthony G Comuzzie; Barbara V Howard; Jason G Umans
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-01-04       Impact factor: 3.738

2.  Increased childhood BMI is associated with young adult serum uric acid levels: a linkage study from Japan.

Authors:  Erika Kuwahara; Yoshitaka Murakami; Tomonori Okamura; Hirokazu Komatsu; Akemi Nakazawa; Hideo Ushiku; Fumio Maejima; Yoshio Nishigaki; Yuji Nishiwaki
Journal:  Pediatr Res       Date:  2016-10-27       Impact factor: 3.756

3.  Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy.

Authors:  Ji Zhang; Min Pan; JianNa Zhang; XiaoHan You; Dou Li; Fan Lin; GuoYuan Lu
Journal:  Int Urol Nephrol       Date:  2019-08-28       Impact factor: 2.370

Review 4.  Effect of uric-acid-lowering therapy on progression of chronic kidney disease: a meta-analysis.

Authors:  Ye-Fang Zhang; Fan He; Hong-Hui Ding; Wei Dai; Qian Zhang; Hong Luan; Yong-Man Lv; Hong-Bing Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

Review 5.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

Review 6.  Secreted klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 7.  [Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].

Authors:  L Sellin; J T Kielstein; K de Groot
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

8.  Association of a polymorphism in a gene encoding a urate transporter with CKD progression.

Authors:  Alessandra Testa; Francesca Mallamaci; Belinda Spoto; Anna Pisano; Maria Cristina Sanguedolce; Giovanni Tripepi; Daniela Leonardis; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 8.237

Review 9.  Comorbidities in patients with crystal diseases and hyperuricemia.

Authors:  Sebastian E Sattui; Jasvinder A Singh; Angelo L Gaffo
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

10.  Sex-Specific Association of Uric Acid and Kidney Function Decline in Taiwan.

Authors:  Po-Ya Chang; Yu-Wei Chang; Yuh-Feng Lin; Hueng-Chuen Fan
Journal:  J Pers Med       Date:  2021-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.